tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LLY Stock Latest News

WeightWatchers Restructures $1.15B Debt, Targets Women’s Health to Compete with Weight-Loss Drug Leaders
Market NewsWeightWatchers Restructures $1.15B Debt, Targets Women’s Health to Compete with Weight-Loss Drug Leaders
3m ago
LLY
NVO
‘Load Up Ahead of Earnings,’ Says J.P. Morgan About Eli Lilly Stock
PremiumMarket News
‘Load Up Ahead of Earnings,’ Says J.P. Morgan About Eli Lilly Stock
5h ago
LLY
NYSE
3 Best Growth Stocks to Buy Now, 7/8/2025, According to Analysts 
PremiumMarket News
3 Best Growth Stocks to Buy Now, 7/8/2025, According to Analysts 
7h ago
LLY
FICO
Eli Lilly’s Tirzepatide Study: A Potential Game-Changer for Adolescent Obesity
PremiumCompany Announcements
Eli Lilly’s Tirzepatide Study: A Potential Game-Changer for Adolescent Obesity
9h ago
LLY
Eli Lilly and AstraZeneca’s Promising Phase 3 Study on Lung Cancer Treatment
PremiumCompany Announcements
Eli Lilly and AstraZeneca’s Promising Phase 3 Study on Lung Cancer Treatment
9h ago
AZN
LLY
Eli Lilly’s Promising Pediatric Crohn’s Disease Study: A Potential Game Changer
PremiumCompany AnnouncementsEli Lilly’s Promising Pediatric Crohn’s Disease Study: A Potential Game Changer
9h ago
LLY
Eli Lilly’s Mirikizumab Study: A Potential Game-Changer for Ulcerative Colitis Treatment
Premium
Company Announcements
Eli Lilly’s Mirikizumab Study: A Potential Game-Changer for Ulcerative Colitis Treatment
9h ago
LLY
Eli Lilly’s Alzheimer’s Study: A Potential Game-Changer for Early Intervention
Premium
Company Announcements
Eli Lilly’s Alzheimer’s Study: A Potential Game-Changer for Early Intervention
9h ago
LLY
Eli Lilly’s Promising Pediatric Study: Mirikizumab’s Potential in Treating Ulcerative Colitis and Crohn’s Disease
PremiumCompany Announcements
Eli Lilly’s Promising Pediatric Study: Mirikizumab’s Potential in Treating Ulcerative Colitis and Crohn’s Disease
9h ago
LLY
Eli Lilly’s SUNRAY-01 Study: A Potential Game-Changer for KRAS G12C-Mutant Lung Cancer
PremiumCompany Announcements
Eli Lilly’s SUNRAY-01 Study: A Potential Game-Changer for KRAS G12C-Mutant Lung Cancer
9h ago
LLY
Eli Lilly’s New Diabetes Drug Trial: A Potential Game-Changer?
PremiumCompany Announcements
Eli Lilly’s New Diabetes Drug Trial: A Potential Game-Changer?
9h ago
LLY
Eli Lilly’s Tirzepatide Study: A Potential Game-Changer for Kidney Health
PremiumCompany Announcements
Eli Lilly’s Tirzepatide Study: A Potential Game-Changer for Kidney Health
9h ago
LLY
Eli Lilly’s Pediatric Diabetes Study: A New Frontier for Dulaglutide
PremiumCompany AnnouncementsEli Lilly’s Pediatric Diabetes Study: A New Frontier for Dulaglutide
9h ago
LLY
Eli Lilly’s REBUILD-1 Study: A Potential Game-Changer for Pediatric Migraine Treatment
Premium
Company Announcements
Eli Lilly’s REBUILD-1 Study: A Potential Game-Changer for Pediatric Migraine Treatment
9h ago
LLY
Eli Lilly’s CAMPFIRE Study: A New Dawn for Pediatric Cancer Research
Premium
Company Announcements
Eli Lilly’s CAMPFIRE Study: A New Dawn for Pediatric Cancer Research
9h ago
LLY
Eli Lilly’s Baricitinib Study: A Potential Game-Changer for Juvenile Arthritis
PremiumCompany Announcements
Eli Lilly’s Baricitinib Study: A Potential Game-Changer for Juvenile Arthritis
9h ago
LLY
Eli Lilly’s New Pediatric Diabetes Study: A Potential Game-Changer?
PremiumCompany Announcements
Eli Lilly’s New Pediatric Diabetes Study: A Potential Game-Changer?
9h ago
LLY
Eli Lilly’s Galcanezumab Study: A Potential Game-Changer for Adolescent Migraine Treatment
PremiumCompany Announcements
Eli Lilly’s Galcanezumab Study: A Potential Game-Changer for Adolescent Migraine Treatment
9h ago
LLY
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
PremiumThe Fly
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
11h ago
AZN
BMY
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
PremiumThe FlyPharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
11h ago
AZN
BMY
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth
Premium
Ratings
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth
16h ago
LLY
Eli Lilly (LLY) Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive
Premium
Market News
Eli Lilly (LLY) Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive
1d ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >